This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
However, there has not been a clinicaltrial assessing the efficacy of cannabis for migraines, at least not until now. Science Alert has announced that the first clinicaltrial for cannabis as a migraine treatment is underway. The First ClinicalTrial for Migraines and Cannabis.
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
Many patients are turning to cannabis for insomnia relief, seeking its potential to improve sleep quality and duration. Insomnia is a common sleep disorder characterized by difficulty falling asleep, staying asleep, or experiencing non-restorative sleep despite having the opportunity to sleep.
#image_title Medical Marijuana is becoming a widely used treatment for anxiety and mood disorders like PTSD (Post-Traumatic Stress Disorder). Fear Extinction: THC has been shown to facilitate the extinction of fear memories, a crucial process for PTSD treatment. Sleep Improvement: Many PTSD sufferers experience insomnia and nightmares.
While traditional treatments like antiepileptic drugs exist, they may not always provide adequate relief for all patients. In recent years, there has been growing interest in exploring alternative treatment options, and one that has gained attention is medical marijuana (MMJ).
The Dementia Society of America attributes Dementia to rising healthcare costs as billions are spent each year for treatments and research. Pharmaceutical treatments for for Dementia often only target symptoms like pain or depression, but those medicines do not cure or prevent the disease.
CBN is a popular cannabinoid, but what should we know about CBN and sleep? Currently, CBN is mostly used by the general population as a sleep-inducing aid. However, it may do more than just induce sleep—many fans of CBN report that it makes for longer-lasting, more satisfying sleep. CBN and Sleep: FAQs.
Other symptoms of mild TBI include headache, confusion, lightheadedness, dizziness, blurred vision or tired eyes, ringing in the ears, bad taste in the mouth, fatigue or lethargy, a change in sleep patterns, behavioral or mood changes, and trouble with memory, concentration, attention, or thinking. Relieve pain, inflammation and nausea.
Of course, this plant is now known to be marijuana (or Type I cannabis), which is still commonly used for sleep and analgesia today. CBN has been receiving a lot of attention for its ability to induce sleep, as it’s frequently marketed as nature’s sleep aid. What can the current clinicaltrials tell us?
Post-Traumatic Stress Disorder (PTSD) is a multifaceted mental health condition triggered by experiencing or witnessing traumatic events, persistently manifesting in symptoms like flashbacks, severe anxiety, and disrupted sleep. Research suggests that cannabinoids may modulate these processes, potentially offering relief from PTSD symptoms.
The most common health conditions among the sample group were anxiety (51.2%), chronic pain (40.9%), depression (33.1%), and insomnia/distrubed sleep (30.7%). No clinicaltrial was used in the compilation of the study. There are some marked limitations with the survey, however. For one, it involved a very small sample size.
And it does appear to address some of the main issues that people turn to cannabis for — inflammation, pain, anxiety, sleep problems, depression, and cancer. It was highly rated for anxiety, pain, depression, and sleep problems. But we may be on the cusp of having those trials, which would be very exciting.
Virtual ClinicalTrials transcend geographic, mobility and economic barriers. Clinicaltrials are medical research projects involving human participants. However, the costs of conducting a full-scale clinicaltrial can be prohibitive, posing barriers to research for cannabis companies.
As if those weren’t enough, the fear of the virus alone can also wreak havoc on sleep patterns. Patients around the world are reporting a sharp increase in sleep problems, and physicians have coined the term coronasomnia to describe the phenomenon. A team of researchers is studying the coronavirus-era sleep crisis.
Taken together, the lack of guidance and lack of information about what treatments patients are taking, may underlie “inconsistencies in both use and reported effectiveness,” the researchers stated. Here are the most interesting statistics from the survey. Those who use high THC products were 7.43 An overwhelming 84.7%
. * The most common non-motor symptoms that cannabis users were trying to treat with their cannabis use were anxiety, pain, and sleep disorders. Non-uses were also asked what factors might cause them to consider adding medical marijuana to their treatment regime. The remainder reported partial or no relief.
Traditional treatments, while helpful to some extent, often come with limitations and side effects that can further burden individuals already dealing with a debilitating disease. Medical marijuana has emerged as a promising alternative treatment option for managing symptoms associated with MS.
Immune System and Sleep Deprivation. Overproduction or underproduction of cortisol can both cause problems with sleep (insomnia), as well as leading to a weakened response from your immune cells when they’re needed most—when you’re sick or fighting off an infection! the cavities around your nose). We Need More Research.
Cannabis oil is being used successfully in combination with chemotherapy and radiation to kill cancer but also to help unwanted side effects such as nausea, loss of appetite, sleep disturbances, depression, anxiety, and pain. Of 272 combined patients, 86% experienced some clinical benefit, and 10% experienced a complete clinical response.
Both IBD and IBS have a major impact on the quality of life and on the ability to do simple things such as eat, sleep, and work. Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . Diet is used as the primary treatment. . What is IBD?
(OTCQB: SPRCY ) a specialty, clinical-stage pharmaceutical company focusing on the development of cannabinoid-based treatments, today announced positive top-line results for its proprietary compound, SCI-160 in a controlled pre-clinicaltrial on neuropathic and post-operative pain. ” About The Study.
According to data on Healthy Place , treatment for PTSD is typically accommodated for the general public, of who the vast majority have not experienced military combat. At this time, there is little in the way for combat-related PTSD treatment specifically. But veterans utilize general PTSD treatment and still experience recovery.
Epilepsy Management: CBD, in particular, has emerged as an effective treatment for epilepsy, especially in individuals with rare and severe forms of the condition. Neurological Disorders: Several cannabinoids show promise in the treatment of neurological disorders, including multiple sclerosis (MS) and Parkinson’s disease.
According to clinicaltrials, CBD decreases pro-inflammatory cytokines, inhibits T cell proliferation, causes T cell death, and inhibits immune cell migration and adhesion. CBD, typically in combination with THC, has been a helpful pain treatment for various chronic disease studies. Improves Sleep Cycle. Your Takeaway.
Cannabis is an effective tool for the treatment of topical skin conditions In a recent study by undertaken by MGC Pharma, our dermatologists found that CBD is effective in providing relief for relief for dry, red, flakey, oily and acne prone skin through CBD skincare.
The objective of the survey published in December 2020 explored “ the effect that medical cannabis has on prescription opioid medication usage for the treatment of chronic pain at three medical cannabis practice sites ”. The Effect of Medical Cannabis on Prescription Opioids.
My partner, who was diagnosed with Crohn’s Disease at the age of 19, was able to improve his quality of life with cannabis by managing his nausea, poor quality sleep, gut motility, appetite, pain, and anxiety with a single substance. The more I read about it, the more I became fascinated with the chemistry and potential of cannabis.
-1000s of UK athletes regularly taking CBD to manage pain, sleep disorders and anxiety – -Football, Rugby, Cricket, Hockey and Golf stars want clarity from governing bodies-. -UK The fact is that 1000s of UK athletes are choosing CBD to manage pain as an alternative to standard pharmacological treatments.
CBD has been suggested to act as a treatment for sclerosis symptoms, as well as epilepsy among children. Apart from this, various clinicaltrials are done for multiple conditions. Furthermore, CBD is often advertised to be effective for treating post-traumatic stress disorder, as well as facilitating sleep. Dehydration.
Conventional medication methods such as opiates may help terminal patients focus on more palliative treatment options and goals in order to better one’s comfort and overall quality of life during this time. One study from the Journal of Clinical Oncology examined the efficacy of cannabinoids in appetite stimulation.
Cannabis & Dementia: New Study Explores Pot’s Potential for Treatment. In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression.
Classified as a neurological disorder, typical treatments include neuropathic painkillers that come with unpleasant side effects. Finding a natural alternative to these strong pharmaceuticals- one that doesn’t come with such downsides- could improve the lives of many sufferers. appeared first on The Joint Blog.
In recent years, a significant shift has occurred in the perception of medical marijuana, transforming it from a controversial substance to a recognized and, in some places, a legal form of medical treatment. Both THC and CBD contribute to the sedative effects, helping individuals fall asleep faster and enjoy a more restful sleep.
Chronic pain persists over a long period of time and is resistant to most medical treatments. If you are suffering from chronic pain, you may experience greater relief if your doctors add cannabinoids – the main ingredient in cannabis or medical marijuana – to an opiates-only treatment.
This was the birth of the world’s first sleeping pill. The substance was first synthesized for the treatment of tuberculosis but they found that the patients were exhibiting euphoric and hyperactive behavior. Viagra was accidentally discovered when researchers were looking for a treatment for chest pain. Heart Pacemaker.
Traditional treatments, such as medications and physical therapy, usually fall short of providing effective relief. How to Use Medical Marijuana for Neuropathy Chronic nerve pain can be challenging to manage, but medical marijuana offers support to traditional treatments. Your healthcare provider can help you choose the optimal choice.
He ran clinicaltrials for big pharma’s GW Pharmaceuticals research division on Epidiolex. Epidiolex is an FDA approved cannabis-based pharmaceutical manufactured drug used in the treatment of seizures. Anup Patel is the most perplexing. Dr. Patel is a member of the Nationwide Children’s Hospital.
The outcomes and measures used throughout the trial included changes in CUD symptoms; anxiety and depressive symptoms; pain severity; and insomnia symptoms. ClinicalTrial Sample Size. Daily Cannabis Use as a Disqualifier.
We’re exploring the world of CBD, uncovering the benefits of CBD in medical marijuana, its impact on health, its potential as a treatment option, and what you need to know about its use in medical marijuana. CBD: A Promising Treatment Option One of the most compelling aspects of CBD is its versatility as a treatment option.
VA providers can and do discuss marijuana use with veterans as part of comprehensive care planning, and adjust treatment plans as necessary. VA health care providers will record marijuana use in the veteran’s VA medical record in order to have the information available in treatment planning. VidaCann : 15% discount.
5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. May not be reprinted without permission from the source. Neuropharmacology.
During the four-week study, participants will use the Radicle Science platform to track consumption and effectiveness of orally ingested CBD products on well-being, quality of life, pain, sleep disturbance, and anxiety. We are delighted to have Lord Jones involved in the Radicle Sciences’ ACES study.
This is despite a limited number of high-quality clinicaltrials investigating the drug’s efficacy for this condition. Using data from the Therapeutic Goods Administration (TGA) – Australia’s Special Access Scheme B, the researchers found the other two top reasons for prescriptions were pain and sleep disorders.
In the Australian clinical study, cannabinoids will be extracted and delivered in a mouth spray, making it easier to be administered to the elderly. The clinicaltrial will be held over a 14-month period starting early next year. Medicinal cannabis is also thought to increase appetite as well as improve sleep cycles.”.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content